Although the present study has some limitations, such as a limited number of clinical samples and the unknown specific binding sites between TET1 and HDAC1, it expands our understanding of the biological function of TET1 in metabolic diseases and provides a new perspective to reveal the pathogenesis of hyperthyroidism. The gene discussed is HDAC1; the disease is Other metabolic disease.